Speaker illustration

Doctor Andrea Denegri

Hospital of Parma, Parma (Italy)

Member of:

EAPCI

Dr. med Andrea Denegri graduated in 2007 at the University of Genova, Italy. He achieved the Board Certification in Internal Medicine in 2013 and, thereafter, the Board Certification in Cardiology in 2017 at the University Hospital of Zürich under the supervision of Prof. Thomas F. Lüscher. In 2018 he obtained the PhD-title in Clinical and Experimental Internal Medicine at University of Genova discussing a dissertation on renal denervation. He awarded a 2-years research fellowship funded by the SNF and a 1-year interventional cardiology fellowship at Zurich University Hospital. He is author and co-author of papers published in international peer-review journals and attended various international congresses. Main expertise: interventional cardiology and development and management of clinical trials. Research interests: coronary and structural interventional cardiology, resistant hypertension and cardiotoxicity from chemotherapy.

Prevalence and outcomes of peripheral artery disease in a real-world cohort of patients with acute coronary syndrome: insights from the prospective SPUM registry

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Different aspects of acute coronary syndromes

Thumbnail

Systemic immune-inflammation index predicts major adverse cardiovascular events in patients with ST-elevation myocardial infarction

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Coronary Syndromes ePosters

Thumbnail

Uncontrolled hypertension and elevated NT-proBNP predict acute kidney injury and cardiac death in all-comer patients 1 year after acute coronary syndromes.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Coronary Syndromes ePosters

Thumbnail

The perils of polyvascular disease with concomitant type 2 diabetes in a real-world cohort of patients with acute coronary syndrome

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary Artery Disease: Diabetes kidney

Thumbnail

Baseline inflammatory markers, NT-proBNP and LVEF predict heart failure and cardiac death one year after acute coronary syndromes

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Best Posters in cardiogenic shock

Thumbnail

ESC 365 is supported by

logo Novo Nordisk